FGF-15 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TGF-β RI Kinase Inhibitor VIII | 356559-20-1 | sc-203295 | 2 mg | $100.00 | 2 | |
Also called SB-525334, this compound is a selective inhibitor of the TGF-β receptor I (ALK5). By specifically targeting the TGF-β signaling pathway, it indirectly modulates FGF-15 activity by influencing the cross-talk between these pathways. | ||||||
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
AZD4547 is an FGFR kinase inhibitor that directly inhibits FGF receptor activity, suppressing downstream signaling cascades. This compound can modulate FGF-15 by interrupting the FGFR-mediated pathways it is involved in. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
PD173074 is a potent FGFR inhibitor that directly targets FGFR tyrosine kinase activity. Its inhibitory effects on FGFR signaling pathways indirectly impact FGF-15 by disrupting shared components of the signaling cascades. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
SU5402 is a small molecule inhibitor of FGFR and VEGFR tyrosine kinase activity. It indirectly influences FGF-15 by disrupting the shared downstream signaling pathways of FGFR and, consequently, FGF-15 activity. | ||||||
Cediranib | 288383-20-0 | sc-483599 sc-483599A sc-483599B | 5 mg 10 mg 25 mg | $137.00 $220.00 $406.00 | ||
Cediranib is a multi-targeted receptor tyrosine kinase inhibitor with inhibitory effects on FGFR. By targeting the FGFR pathway, it indirectly modulates FGF-15 activity through the disruption of shared downstream signaling components. | ||||||
BGJ398 | 872511-34-7 | sc-364430 sc-364430A sc-364430B sc-364430C | 5 mg 10 mg 50 mg 100 mg | $216.00 $252.00 $594.00 $1009.00 | 4 | |
BGJ398 is a selective pan-FGFR inhibitor that directly hinders FGFR kinase activity. This compound indirectly influences FGF-15 by disrupting the specific signaling pathways where FGFR and FGF-15 interact. | ||||||
PD 166866 | 192705-79-6 | sc-208154 | 5 mg | $300.00 | 1 | |
PD166866 is a selective FGFR inhibitor that directly interferes with FGFR kinase activity. Its inhibitory effects on FGFR signaling pathways indirectly impact FGF-15 by disrupting the shared components of the signaling cascades. | ||||||
Dovitinib, Free Base | 405169-16-6 | sc-396771 sc-396771A | 10 mg 25 mg | $170.00 $350.00 | ||
Dovitinib, Free Base is a multi-targeted receptor tyrosine kinase inhibitor with inhibitory effects on FGFR. By targeting the FGFR pathway, it indirectly modulates FGF-15 activity through the disruption of shared downstream signaling components. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $175.00 $983.00 | 2 | |
AP 24534 is a multi-targeted tyrosine kinase inhibitor with inhibitory effects on FGFR. By targeting the FGFR pathway, it indirectly modulates FGF-15 activity through the disruption of shared downstream signaling components. | ||||||